Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JLuis, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, et al.
Lancet Neurol. 2014 Jun; 13(6):614-29. PMID: 24849862. Abstract
Top50 Topics: 


Submitted by Wei Chen on

They consider that volumetric MRI and fluorodeoxyglucose PET are important in the measurement and monitoring of the course of AD disease, and also elaborates on the diagnostic criteria for for the preclinical states of AD.